Immune checkpoint inhibitors may work along with LDH-A inhibition to unleash host inflammatory T lymphocytes that will preferentially assault tumor cells, as lactate has been reported to limit T-cell cytotoxicity [135]. This evidence concerns the gene LDHA and neoplasm.